Introduction
Although up to 96% of patients report some degree of pain 1 when prostate biopsy is performed, the standard of care has been to ignore this as a necessary downside to the procedure. 2 Some recent publications have suggested pain may be controlled by periprostatic administration of local anesthetic, 3 -5 but others have shown no benefit. 6 Based on these early reports, we assessed feasibility of pain control using periprostatic injection of lidocaine on a randomized basis.
Materials and methods
Based on our preliminary observations that pain scores were decreased at least by half, the Department of Biostatistics and Epidemiology randomized 30 patients to receive either periprostatic lidocaine (group one) or no anesthetic (group two). Blinded randomization envelopes were opened immediately prior to biopsy.
Patients were placed in the left lateral decubitus position and the ultrasound probe was inserted transrectally. If patients were randomized to group one, the probe was turned to the saggital plane with the biopsy guide switched on prior to placement. A 22 gauge, 7-inch spinal needle was placed through the biopsy guide channel under ultrasound guidance into the area where the prostatic innervation enters the gland. This was identified by angling laterally until the notch between prostate and seminal vesicle was visualized. The needle was placed into this notch and 5 cm 3 plain lidocaine were injected on each side. Successful placement was confirmed by observing the injectate cause separation of the seminal vesicles and prostate from the rectal wall.
Ultrasound examination and volume calculation were then performed in both groups per routine. Ten biopsies were taken immediately using a spring-loaded biopsy needle as described by Gore et al. 7 Biopsies specifically included any visible abnormalities.
All patients were asked to report a validated linear visual analog scale (VAS) score, with 0 denoting no pain and 10 equaling the worst pain the patient had ever experienced. In order to minimize investigator bias, all VAS scores were obtained by the nurse after the physician left the room.
Results
Mean VAS scores were over threefold higher in control patients than in those who received local anesthetic (1.4 vs 4.5; P < 0.0001). Due to the dramatic difference in the two groups, the study was closed prior to enrollment of the last five patients.
Only one patient in group one reported a pain score (4) in the moderate range of 4 -7. In contrast, the majority of patients in group two reported pain scores in the moderate or severe ranges (28.6% in each). There was no difference in VAS scores among patients in either group when analyzed by individual surgeon. The results are summarized in Table 1 .
Injection of local anesthetic was completed in less than 60 s in all patients. There was no additional time delay taken before proceeding to biopsy in any patient.
Pain was the only complication in either group. All patients were given 4 days ciprofloxacin 500 mg twice daily beginning the day before the biopsy. No infections were observed. Most patients in both groups noted minor urinary, rectal and seminal (if sexually active) bleeding, but none required treatment.
Prostate cancer was identified in nine group A patients and 10 group B patients. Radical prostatectomy was performed in six patients from each group. A nervosparing procedure was performed in five patients injected with lidocaine. No scarring or other evidence of damage from the injection was observed.
Discussion
Up to 96% of patients that undergo prostate biopsy report pain, but until recently this was ignored as a necessary downside to the procedure. The most recent edition of Campbell's Urology states that anesthetic is not needed. 2 However, from the patient's standpoint a very different view emerges. Almost one in five patients in a recent study declared they would refuse re-biopsy without general anesthetic. 8 This is consistent with our findings that 29% of patients biopsied without anesthetic complained of severe pain.
Prostatic anesthesia is achieved by blocking the prostatic sensory branches of the neurovascular bundles, which originate in the pelvic plexus. These branches exit the neurovascular bundles posterolaterally as they course between rectum and prostate ( Figure 1 ). Although some investigators inject these nerves in three or four different sites on each side, 9 a single injection as these nerves approach the prostatic base on each side prior to branching should be sufficient based on the neuroanatomy. This has been confirmed by our findings, in which all but one patient early in the series received complete pain relief.
The other source of pain during prostate biopsy is the rectum, where the only pain sensory innervation is below the dentate line. Before we began performing periprostatic anesthesia, we believed the apex was more sensitive to pain than the rest of the gland as reported by Kaver. 10 We now believe the increased pain experienced with apical biopsy is due to the inferior rectal nerve pain fibers below the dentate line. If the patient can feel the needle lightly touching rectal mucosa overlying the apex, we move slightly cephalad prior to passing through the rectal wall. The needle is then angled back towards the apex for these two apical biopsies. This avoids rectal sensory pain fibers below the dentate line, and has been better tolerated in non-randomized observation of patients biopsied after completion of the study.
We acknowledge the lack of placebo control. However, to limit bias, we avoided coaching patient responses by telling patients only that they might 'feel a stick', whether or not they were receiving an anesthetic. This was consistent with the non-randomized approach we used prior to beginning the study as the investigators developed the technique. Surgeons left the room immediately after biopsy and VAS scores were recorded as soon as possible by the nurse to minimize bias as well.
All patients in the Urological Institute are routinely asked to give a VAS score on every patient visit -a policy instituted after review by the Joint Commission of Hospital Accreditation (JCAHO). This makes it unlikely that patient responses were affected by the inquiry about their pain.
Despite these measures, it is still feasible that the results were affected by the lack of blinding physician and patient. Figure 1 Correct needle placement is shown in the notch between seminal vesicle and prostate laterally.
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As pain is subjective, patients might perceive greater care being taken to assure their comfort. In addition, the surgeons might have been gentler in the study group. However, there was no difference in pain scores when controlling for individual surgeon, indicating that if there was difference in surgeon technique when using anesthetic, the same difference was carried out among the five surgeons equally. This appears unlikely. It is even more unlikely that this could result in a three-fold difference in VAS scores. Operator technique will surely affect pain perception during any office-based procedure. Gentle probe placement through the anal sphincter minimizes patient anxiety, potentially affecting pain experienced during the biopsy punctures. The number and vigor of biopsies will affect results.
VAS scores of controls in the published literature range from 2.5 6 to 5.0. 11 This variation could result from intrainstitutional differences in technique, study populations or in data collection. The specific question asked is a variable difficult to quantify. It is unclear from published reports whether patients were asked about total pain experience, including probe insertion, or just pain from the biopsy puncture. Our patients were asked specifically about their total pain experience. Probe insertion discomfort is not altered by this technique, so this will contribute to the pain experience of both patients and controls. 12 This could explain why the study of Wu et al 6 found lower VAS scores among controls, as they apparently asked patients to rate their pain only for the biopsy procedure alone. Study populations will also experience pain differently, based on regional, age or socioeconomic factors. Therefore, comparing pain scores between studies from different institutions is difficult. However, within the same population as shown in our study, local anesthetic appears to offer substantial benefit during biopsy as performed in our institution by five different physicians.
Injection of local anesthetic into the area of the neurovascular bundles would appear to have the potential to cause scarring. If so, nerve-sparing prostatectomy would be theoretically more difficult. However, we have specifically assessed the area of injection at the time of each operation. In no case thus far has scarring been observed. In addition to the five patients in this study, we have performed nerve-sparing radical retropubic prostatectomy on over 30 patients outside this study group and in no case has nerve sparing been more difficult than usual.
The technique is easily mastered in one or two cases by urologists experienced in transrectal ultrasound. Success is based on placement of anesthetic in the proper site. This is most easily identified by the 'Mount Everest' sign, a hyperechoic (due to periprostatic fat) pyramidal notch between prostate and seminal vesicle seen laterally in the saggital plane (Figure 2 ). When this site is injected, an 'ultrasonic wheal' is seen to separate the rectum away from the prostate and seminal vesicles. This wheal has not made visualization more difficult.
Conclusion
This study confirms that most patients complain of moderate to severe pain with prostate biopsy unless local anesthesia is given. Periprostatic injection of local anesthesia prevents prostate biopsy pain when performed as described. The technique is easily mastered and reproducible. No difficulty has been encountered with nerve sparing during radical prostatectomy in patients who have undergone the procedure. The additional time required is minimal and does not otherwise delay biopsy.
